Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H22N2O3S |
| Molecular Weight | 322.422 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(NC1CCCCC1)NS(=O)(=O)C2=CC=C3CCCC3=C2
InChI
InChIKey=NFRPNQDSKJJQGV-UHFFFAOYSA-N
InChI=1S/C16H22N2O3S/c19-16(17-14-7-2-1-3-8-14)18-22(20,21)15-10-9-12-5-4-6-13(12)11-15/h9-11,14H,1-8H2,(H2,17,18,19)
| Molecular Formula | C16H22N2O3S |
| Molecular Weight | 322.422 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Glyhexamide (SQ 15,860) is a sulfonylurea with antihyperglycemic activity. Its hypoglycemic effect was first observed in rats, dogs and rabbits when orally administered, in 1965. This hypogelycemic activity was however not accompanied by increases in serum (immunoreactive) insulin concentrations.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:24 GMT 2025
by
admin
on
Mon Mar 31 17:50:24 GMT 2025
|
| Record UNII |
WW7NA7WQD2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000084253
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
451-71-8
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
9953
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
SUB07953MIG
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
WW7NA7WQD2
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
DTXSID70196383
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
106960
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
C170032
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
m5812
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1968544
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
3271
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY | |||
|
1946
Created by
admin on Mon Mar 31 17:50:24 GMT 2025 , Edited by admin on Mon Mar 31 17:50:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |